---
figid: PMC9316959__pharmaceutics-14-01380-g004
figtitle: Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular
  Carcinoma
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Caenorhabditis elegans
- Hepatitis B virus
- NA
pmcid: PMC9316959
filename: pharmaceutics-14-01380-g004.jpg
figlink: /pmc/articles/PMC9316959/figure/pharmaceutics-14-01380-f004/
number: F4
caption: Regulation of metastasis of cancer cells by miR-122. Without any external
  stimulation, β-catenin is phosphorylated by the degradation complex kinases, comprising
  glycogen synthase kinase 3 (GSK3) and casein kinase 1α (CK1α). This leads to the
  degradation of β-catenin by the ubiquitin–proteasome pathway. The binding of the
  Wnt protein to the Frizzled receptor and co-receptors, such as the low-density lipoprotein
  receptor-related protein 5 (LRP5) or LRP6, initiates the dissociation of the degradation
  complex kinases, thereby stabilizing β-catenin and leading to the expression of
  Wnt target genes. miR-122 can downregulate the expression of WNT, BCL9, and vimentin,
  leading to the loss of their metastatic ability. The TGF-β signaling suppresses
  apoptosis and promotes EMT at the later stages of hepatocellular carcinoma (HCC)
  development. The activation of TGF-β transduces a signal through Smad proteins.
  Also, PEG10 regulates TGF-β signaling positively in HCC. miR-122 downregulates the
  expression of TGF-β, TβRI, and PEG10. TGF-β signaling can also enhance the EGFR
  signaling by activating ADAM17. Signaling by the AXL receptor, another target of
  miR-122, also contributes to the metastasis of HCC by activating PI3k/Akt, JAK/STAT,
  NF-κB, and MAPK pathways.
papertitle: Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular
  Carcinoma.
reftext: Kwang-Hoon Chun. Pharmaceutics. 2022 Jul;14(7):1380.
year: '2022'
doi: 10.3390/pharmaceutics14071380
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: miR-122 | hepatocellular carcinoma | molecular targets | signaling pathways
  | metastasis
automl_pathway: 0.9463248
figid_alias: PMC9316959__F4
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
redirect_from: /figures/PMC9316959__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9316959__pharmaceutics-14-01380-g004.html
  '@type': Dataset
  description: Regulation of metastasis of cancer cells by miR-122. Without any external
    stimulation, β-catenin is phosphorylated by the degradation complex kinases, comprising
    glycogen synthase kinase 3 (GSK3) and casein kinase 1α (CK1α). This leads to the
    degradation of β-catenin by the ubiquitin–proteasome pathway. The binding of the
    Wnt protein to the Frizzled receptor and co-receptors, such as the low-density
    lipoprotein receptor-related protein 5 (LRP5) or LRP6, initiates the dissociation
    of the degradation complex kinases, thereby stabilizing β-catenin and leading
    to the expression of Wnt target genes. miR-122 can downregulate the expression
    of WNT, BCL9, and vimentin, leading to the loss of their metastatic ability. The
    TGF-β signaling suppresses apoptosis and promotes EMT at the later stages of hepatocellular
    carcinoma (HCC) development. The activation of TGF-β transduces a signal through
    Smad proteins. Also, PEG10 regulates TGF-β signaling positively in HCC. miR-122
    downregulates the expression of TGF-β, TβRI, and PEG10. TGF-β signaling can also
    enhance the EGFR signaling by activating ADAM17. Signaling by the AXL receptor,
    another target of miR-122, also contributes to the metastasis of HCC by activating
    PI3k/Akt, JAK/STAT, NF-κB, and MAPK pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mir122
  - Rhoa
  - Cdc42
  - Rac1
  - Rnase1l1
  - Wnt2
  - Ctnnb1
  - Ptpra
  - Axin1
  - Csnk1a1
  - Bcl9
  - Snai1
  - Tgfb1
  - Tgfbr1
  - Smad2
  - Smad3
  - Smad4
  - Egfr
  - Adam17
  - Akt1
  - Pik3cg
  - Nfkb1
  - Myc
  - Gas6
  - Axl
  - MIR122
  - RHOA
  - CDC42
  - RAC1
  - RNASE1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ADAR
  - DVL1P1
  - CTNNB1
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - HNF4A
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3A
  - GSK3B
  - BCL9
  - SNAI1
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR2
  - TGFBR1
  - SMAD2
  - SMAD3
  - SMAD4
  - EGFR
  - ADAM17
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - NFKB1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MYC
  - GAS6
  - AXL
  - Shh
  - Lrp1
  - Mvp
  - Txlng
  - Gm12892
  - Gsk3b
  - Ltbp1
  - Tgfbr2
  - Pik3r1
  - Nol3
  - cdc-42
  - gsk-3
  - snai-1
---
